• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

ELACRIDAR Drug Record

  • Summary
  • Interactions
  • Claims
  • ELACRIDAR chembl:CHEMBL396298

    Alternate Names:

    ELACRIDAR

    Drug Info:

    Drug Categories benzocycloheptenes
    Drug Categories drug resistance, multiple
    Drug Categories heterocyclic compounds, fused-ring
    Drug Categories p-glycoprotein inhibitors
    (0 More Sources)

    Publications:

    Hubensack et al., 2008, Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice., J. Cancer Res. Clin. Oncol.
    Xiao G et al., 2012, Cerebrospinal fluid can be used as a surrogate to assess brain exposures of breast cancer resistance protein and P-glycoprotein substrates., Drug Metab Dispos
  • ELACRIDAR   ABCG2

    Interaction Score: 1.33

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22266779


    Sources:
    DTC PharmGKB

  • ELACRIDAR   ABCB1

    Interaction Score: 0.34

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17932689


    Sources:
    DrugBank PharmGKB

  • DrugBank: DB04881

    • Version: 5.1.7

    Alternate Names:
    ELACRIDAR DrugBank Drug Name
    143664-11-3 CAS Number
    CHEMBL396298 ChEMBL ID

    Drug Info:
    Drug Type small molecule
    Drug Groups investigational
    Drug Categories bcrp/abcg2 inhibitors

    Publications:
    Hubensack et al., 2008, Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice., J. Cancer Res. Clin. Oncol.

  • DTC: ELACRIDAR

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL396298 ChEMBL Drug ID

    Drug Info:

    Publications:
    Xiao G et al., 2012, Cerebrospinal fluid can be used as a surrogate to assess brain exposures of breast cancer resistance protein and P-glycoprotein substrates., Drug Metab Dispos

  • ChemblDrugs: chembl:CHEMBL396298

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • PharmGKB: elacridar

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21